AstraZeneca and Oxford University: Confirms immune response in elderly, phase 3 vaccine trial results in weeks
Read more on https://www.fxstreet.com
Full Article
AstraZeneca and Oxford University: Confirms immune response in elderly, phase 3 vaccine trial results in weeks
FXstreet.com
0 shares
1 views
You might like
Related news coverage
Moderna boss says its COVID-19 vaccine should be given to vulnerable
Proactive Investors
Moderna Inc (NASDAQ:MRNA) has confirmed its COVID-19 vaccine achieved a 94% success in its recent phase III trial and that it will..
-
Volunteer seeks investigation on Serum after developing complication but company is intimidating
Mid-Day
-
AstraZeneca mulls new coronavirus vaccine trial following results confusion
Proactive Investors
-
AstraZeneca manufacturing error clouds Oxford vaccine study results
Mid-Day
-
AstraZeneca says it will likely do another study of COVID-19 vaccine after accidental lower dose shows higher efficacy
TechCrunch
Advertisement
More coverage
Wall Street mixed as vaccine optimism cheers traders, tech struggles
Proactive Investors
12:30 pm: A third promising vaccine has emerged After a strong open, US markets gave back some gains. At midday, the Dow improved..
-
US stocks close higher on vaccine optimism as Biden taps ex-Fed Chair Yellen as Treasury secretary
Proactive Investors
-
US benchmarks start the week higher as more vaccine optimism cheers traders
Proactive Investors
-
Oxford University’s COVID-19 vaccine shows high efficacy, and is cheaper to make and easier to store
TechCrunch
-
US stocks seen pushing higher as optimism grows that coronavirus vaccines will soon be rolled out
Proactive Investors